CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
2.560
+0.090 (3.64%)
Dec 20, 2024, 4:00 PM EST - Market closed
CytoMed Therapeutics Market Cap
CytoMed Therapeutics has a market cap or net worth of $29.54 million as of December 20, 2024. Its market cap has decreased by -30.56% in one year.
Market Cap
29.54M
Enterprise Value
24.83M
1-Year Change
-30.56%
Ranking
Category
Stock Price
$2.56
Market Cap Chart
Since the IPO on April 14, 2023, CytoMed Therapeutics's market cap has decreased from $46.12M to $29.54M, a decrease of -35.94%. That is a compound annual growth rate of -23.19%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Dec 20, 2024 | 29.54M | -47.71% |
Dec 29, 2023 | 56.49M | 22.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Anebulo Pharmaceuticals | 28.79M |
IGC Pharma | 28.50M |
IRIDEX | 28.45M |
RAPT Therapeutics | 28.24M |
Calidi Biotherapeutics | 28.01M |
KALA BIO | 27.66M |
RenovoRx | 27.58M |
Forte Biosciences | 27.28M |